Osteoporosis (OP), a common systemic metabolic bone disease, is characterized by low
bone mass, increasing bone fragility and a high risk of fracture. At present, the clinical …

Osteoporosis is a systemic skeletal disease associated with reduced bone strong point that
results in raised fracture risk, with decreased bone strength, leading to reduced bone …

Osteoporosis-related fractures may severely limit activities of daily living and may require
bed rest, which may become life threatening in elderly people. Osteoporosis has attracted …

Osteoporosis is a debilitating disease that affects millions of people worldwide. Current
osteoporosis treatments are predominantly bone-resorbing drugs that are associated with …

Osteoporosis, or bone loss, is a progressive, systemic skeletal disease that affects millions of
people worldwide. Osteoporosis is generally age related, and it is underdiagnosed because …

Functional impairment of mesenchymal stem cells (MSCs), osteoblast progenitor cells, has
been proposed to be a pathological mechanism contributing to bone disorders, such as …

The field of cell therapy and regenerative medicine can hold the promise of restoring normal
tissues structure and function. Additionally, the main targets of stem cell-based therapies are …

The deterioration of the human skeleton's capacity for self-renewal occurs naturally with age.
Osteoporosis affects millions worldwide, with current treatments including pharmaceutical …

Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and
microstructural degeneration. The personal and societal costs of osteoporosis are …

Osteoporosis is a systemic disease that affects the skeleton, causing reduction of bone
density and mass, resulting in destruction of bone microstructure and increased risk of bone …